Global Large Volume Parenteral (LVP) Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Large Volume Parenteral (LVP) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Large Volume Parenteral (LVP) market share, size, share and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
A Large Volume Parenteral (LVP) is a sterile, single-dose injection available in either a glass bottle or a flexible container. Sterilization is achieved through heat treatment. LVP includes an active ingredient, a water-soluble or non-aqueous vehicle, and supplementary components such as preservatives, buffers, antioxidants, surfactants, tonicity modifiers, and antimicrobial agents. Its applications encompass uses in irrigation solutions, peritoneal dialysis, blood derivatives, contrast agents, and pre-mixed pharmaceuticals. LVP is administered by injecting it directly through the skin or external tissues into organs, blood vessels, tissues, or lesions to deliver the active drug compounds.
The global large volume parenteral (LVP) market size reached US$ 9.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.37% during 2023-2028.
Global Large Volume Parenteral (LVP) Market Trends and Drivers:
The Large Volume Parenterals (LVPs) market is currently on an upward trajectory, driven by several key factors. One pivotal driver is the increasing adoption of LVPs in heart surgery, where they play a crucial role in safeguarding the myocardium from ischemic damage during reperfusion and blood flow restriction. Furthermore, the market is bolstered by the rising incidence of premature births and malnutrition on a global scale. The expanding application of LVPs in the treatment of conditions such as esophageal obstruction, gastrointestinal diseases, cancer, and ulcers is also contributing to market expansion. Additionally, the surging prevalence of non-communicable diseases worldwide is creating lucrative opportunities for investors in the industry. Furthermore, there is a growing demand for safe, effective, and efficient methods of drug administration among patients, which is further propelling a positive outlook for the market.
Global Large Volume Parenteral (LVP) Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Albert David Ltd., B. Braun Melsungen AG, Baxter International Inc., BML Parenteral Drugs, Fresenius Kabi AG, Grifols S.A, Otsuka Pharmaceutical Co. Ltd, Pharmaceutical Solutions Industry Ltd., Sichuan Kelun Pharmaceutical Co. Ltd. and Thermo Fisher Scientific Inc.
The report segmented the market on the basis of region, type, volume, application and end users.
Breakup by Type:
- Soft Bag LVP
- Plastic Bottle LVP
- Glass Bottle LVP
Breakup by Volume:
- 100 ML – 250 ML
- 250 ML – 500 ML
- 500 ML – 1000 ML
- 1000 ML – 2000 ML
- 2000 ML and More
Breakup by Application:
- Therapeutic Injections
- Fluid Balance Injections
- Nutritious Injections
Breakup by End Users:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800